Clinical Trials Logo

Clinical Trial Summary

To explore the epigenetic mechanism of postoperative analgesia and side effect induced by μ-opioid Receptor Agonists presented with sufentanil among general population.


Clinical Trial Description

Patients were interviewed the day before surgery, and taught about the use of PCA pump and VAS. Pressure pain threshold(PPT) and pressure pain tolerance(PTO) were collected before surgery.

Dexmedetomidine1μg/Kg,sufentanil 0.5μg/Kg, propofol 2mg/Kg and rocuronium 0.6mg/Kg were given intravenously for induction. Anesthesia was maintained with inhalation of 1% sevoflurane and infusion of remifentanil (0.2-0.4ug/kg/min) and propofol (6-10mg/kg/h). Aterial blood pressure(ABP),central venous pressure(CVP),SPO2, HR,ETCO2,T and Narcotrend were monitored. Before incision, parecoxib 40mg was given intravenously, and PCA with sufentanil 1ug/ml was started immediately after surgery, suing a controlled infusion pump. The pump was programmed to use a loading dose of 2ml, background infusion at 2m/h, PCA dose of 1ml, lockout time of 10min, and maximal dose of 12ml with 1 h period.

VAS(static), VAS(dynamic), Ramssay, HR, NBP, SpO2, PCA pressing frequency, PCA comsumption were recorded 6h, 12h, 24h, 48h after surgery. Side effects such as nausea, vomiting, respiratory depression; pruritus; abdominal distention; urinary retention and dizziness were also recorded, and corresponding treatment were given.

EDTA anti-coagulated blood was collected from a central venous catheter during the operation. Genomic DNA was extracted from the blood samples, and characteristics and degree of DNA methylation of the gene OPRM1 were analysed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03135795
Study type Interventional
Source Huazhong University of Science and Technology
Contact Ai Ling
Phone +8613667135571
Email aileen911@126.com
Status Recruiting
Phase Phase 4
Start date February 6, 2017
Completion date May 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT02244684 - Effects of Maternal Folate and Folic Acid Supplementation on DNA Methylation in the Newborn Infant N/A
Recruiting NCT03402139 - Early Childhood Obesity Programming by Intrauterine Growth Restriction
Active, not recruiting NCT05766345 - BCG-induced Epigenetic Modifications in the NEXT Generation Phase 4
Not yet recruiting NCT05779904 - Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of Stunted Children
Recruiting NCT05791149 - Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity N/A
Completed NCT03371446 - DNA Methylation Profile of the SOCS-1 Gene Promoter in Smokers Patients With Chronic Periodontitis. N/A
Completed NCT02191683 - Foetal Exposure and Epidemiological Transition: Role of Anaemia in Early Life for Non-communicable Diseases Later
Recruiting NCT05253924 - Biological Underpinnings of Socio-emotional Regulation in Preterm Infants and Healthy Controls
Completed NCT03647449 - Examining the Effects of Juice Fasting N/A
Recruiting NCT04804280 - Epigenetics and Protective Factors in the Preterm Infant
Recruiting NCT03742011 - Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
Suspended NCT04220658 - Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers
Active, not recruiting NCT05892211 - LINE-1 and Alu Methylation Levels Among Middle Aged Women With Low Cardiovascular Risk Profile in Respect of Menopausal Hot Flashes
Recruiting NCT05004090 - Emotional Regulation in Children With ND: the Role of Genomic Variation, Proteomic Patterns, and Early Experience
Completed NCT04608448 - Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock Early Phase 1